Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 62.8 CHF 1.45% Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Balance Sheet

Balance Sheet Decomposition
Cosmo Pharmaceuticals NV

Current Assets 183.6m
Cash & Short-Term Investments 133.4m
Receivables 36.3m
Other Current Assets 13.9m
Non-Current Assets 454.7m
Long-Term Investments 3.2m
PP&E 27.4m
Intangibles 398.5m
Other Non-Current Assets 25.7m
Current Liabilities 37.9m
Accounts Payable 14.7m
Accrued Liabilities 5.3m
Other Current Liabilities 18m
Non-Current Liabilities 101.9m
Long-Term Debt 714k
Other Non-Current Liabilities 101.2m

Balance Sheet
Cosmo Pharmaceuticals NV

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022
Assets
Cash & Cash Equivalents
46
34
71
118
145
211
110
186
199
186
Cash
46
34
71
118
145
211
110
186
199
186
Short-Term Investments
122
25
45
49
28
139
158
27
24
55
Total Receivables
17
8
19
18
20
19
26
32
39
51
Accounts Receivables
12
5
17
15
13
13
19
27
24
39
Other Receivables
6
3
2
3
7
6
7
5
14
12
Inventory
3
3
2
2
3
4
6
6
13
11
Other Current Assets
0
0
0
1
2
2
2
3
2
3
Total Current Assets
188
71
138
187
197
374
302
253
276
306
PP&E Net
22
21
21
21
30
29
30
29
30
30
PP&E Gross
22
21
21
21
30
29
30
29
30
30
Accumulated Depreciation
17
19
22
24
26
30
34
37
41
46
Intangible Assets
16
10
4
20
29
36
49
27
373
366
Goodwill
0
0
0
0
0
1
1
1
24
24
Note Receivable
0
0
0
0
2
2
12
27
35
10
Long-Term Investments
16
121
272
213
230
172
179
251
49
8
Other Long-Term Assets
1
2
2
3
10
12
10
8
19
15
Other Assets
0
0
0
0
0
1
1
1
24
24
Total Assets
243
N/A
226
-7%
438
+94%
443
+1%
498
+12%
626
+26%
585
-6%
596
+2%
806
+35%
760
-6%
Liabilities
Accounts Payable
4
5
4
6
11
9
8
8
8
8
Accrued Liabilities
0
0
0
1
1
1
1
1
6
6
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
2
2
1
1
1
2
3
1
172
Other Current Liabilities
3
53
19
11
6
5
5
10
6
9
Total Current Liabilities
10
61
25
19
19
15
16
22
21
195
Long-Term Debt
10
9
7
4
4
158
163
165
169
2
Deferred Income Tax
3
3
2
4
4
7
9
6
100
97
Minority Interest
0
0
0
0
0
1
0
0
7
7
Other Liabilities
0
0
0
0
0
0
4
3
3
2
Total Liabilities
23
N/A
73
+220%
34
-53%
28
-19%
28
0%
182
+553%
191
+5%
196
+2%
300
+53%
303
+1%
Equity
Common Stock
4
4
4
4
4
4
4
4
5
5
Retained Earnings
156
179
431
437
377
367
346
348
372
341
Additional Paid In Capital
0
0
0
0
84
84
84
84
244
244
Unrealized Security Profit/Loss
63
63
3
3
4
0
4
6
57
50
Treasury Stock
2
2
28
28
0
18
44
49
66
90
Other Equity
0
0
0
0
1
7
7
8
8
8
Total Equity
220
N/A
152
-31%
404
+165%
416
+3%
470
+13%
444
-6%
394
-11%
400
+2%
505
+26%
457
-10%
Total Liabilities & Equity
243
N/A
226
-7%
438
+94%
443
+1%
498
+12%
626
+26%
585
-6%
596
+2%
806
+35%
760
-6%
Shares Outstanding
Common Shares Outstanding
15
14
14
14
15
15
15
14
17
16

See Also

Discover More